Vinzenz Ploerer

Vinzenz Ploerer is Brace Pharma Capital’s President and CEO, and sits on the Board of Directors. Vinzenz is a life science executive with 30+ years of extensive leadership experience in operations, acquisitions, and business development. Prior to launching Brace in 2013, he worked at EMS S/A as Senior Vice President of Strategy and Operations. He has also held multiple senior leadership positions at Novartis/Sandoz including country head of Brazil, Argentina and Head of BDL Sandoz, building the company through acquisitions. Vinzenz currently sits on several corporate boards including GeNO, Therabron, Tyrogenex, and Navitor.

Vinzenz received an MBA from the University of Innsbruck.